Increased dendritic MAP2 expression in the hippocampus in schizophrenia

Microtubule associated proteins (MAPs) are central to the development of normal neuronal cytoarchitecture and have been reported to be altered in schizophrenia. In 12 schizophrenic (DSM-III-R criteria) and 12 control hippocampi, we estimated the MAP2 immunoreactive dendritic length using antibodies that recognize total MAP2 (MAP2-T), and a non-phosphorylated form of MAP2 (MAP2-NP). Within the corona ammonis (CA) subregions, and the subiculum, we estimated, for each antibody, the length of the immunoreactive dendritic arborisation using a stereological length estimation technique based on Bouffon's Needle principle and image analysis computer software. Controlling for the confounding effects of age and post-mortem delay, we have found an elevation in overall MAP2-NP immunoreactive dendritic length among schizophrenic subjects in the CA3 (F = 5.9, p = 0.03), CA2 (F = 6.5, p = 0.02), CA1 (F = 8.3, p = 0.01) and subicular (F = 9.5, p = 0.008) hippocampal subregions. Similar analyses of MAP2-T immunoreactive dendritic length demonstrated significant elevations in the CA1 (F = 8.3, p = 0.02), CA4 (F = 4.9, p = 0.04) and subicular (F = 7.4, p = 0.01) regions. The findings of this quantitative study of increased MAP2 immunoreactive dendritic arborisation in schizophrenia are most likely to reflect either an altered dendritic arborisation or a generalised increase in levels of MAP2 with the hippocampal pyramliteratureidal neurons. These findings add to the growing indicating the presence of synaptodendritic abnormalities in schizophrenia. (C) 2000 Elsevier Science B.V. All rights reserved.